Items per page
Sort by

Send to:

Choose Destination

Results: 16

Cited In for PubMed (Select 15919100)


Inhibition of phosphodiesterase10A attenuates morphine-induced conditioned place preference.

Mu Y, Ren Z, Jia J, Gao B, Zheng L, Wang G, Friedman E, Zhen X.

Mol Brain. 2014 Sep 25;7:70. doi: 10.1186/s13041-014-0070-1.


BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.

Khroyan TV, Wu J, Polgar WE, Cami-Kobeci G, Fotaki N, Husbands SM, Toll L.

Br J Pharmacol. 2015 Jan;172(2):668-80. doi: 10.1111/bph.12796. Epub 2014 Nov 5.


Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD.

Andero R, Brothers SP, Jovanovic T, Chen YT, Salah-Uddin H, Cameron M, Bannister TD, Almli L, Stevens JS, Bradley B, Binder EB, Wahlestedt C, Ressler KJ.

Sci Transl Med. 2013 Jun 5;5(188):188ra73. doi: 10.1126/scitranslmed.3005656.


Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.

Vazquez-DeRose J, Stauber G, Khroyan TV, Xie XS, Zaveri NT, Toll L.

Eur J Pharmacol. 2013 Jan 15;699(1-3):200-6. doi: 10.1016/j.ejphar.2012.11.050. Epub 2012 Dec 5.


Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder.

Logrip ML, Zorrilla EP, Koob GF.

Neuropharmacology. 2012 Feb;62(2):552-64. doi: 10.1016/j.neuropharm.2011.07.007. Epub 2011 Jul 19. Review.


Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.

Lee CW, Yan JY, Chiang YC, Hung TW, Wang HL, Chiou LC, Ho IK.

Neurochem Res. 2011 Nov;36(11):2008-21. doi: 10.1007/s11064-011-0525-z. Epub 2011 Jun 14.


The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.

Podlesnik CA, Ko MC, Winger G, Wichmann J, Prinssen EP, Woods JH.

Psychopharmacology (Berl). 2011 Jan;213(1):53-60. doi: 10.1007/s00213-010-2012-7. Epub 2010 Sep 18.


Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.

Toll L, Khroyan TV, Polgar WE, Jiang F, Olsen C, Zaveri NT.

J Pharmacol Exp Ther. 2009 Dec;331(3):954-64. doi: 10.1124/jpet.109.157446. Epub 2009 Sep 22.


Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.

Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.

J Pharmacol Exp Ther. 2009 Dec;331(3):946-53. doi: 10.1124/jpet.109.156711. Epub 2009 Aug 27.


Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses.

Billa SK, Sinha N, Rudrabhatla SR, Morón JA.

Eur J Neurosci. 2009 Jan;29(1):55-64. doi: 10.1111/j.1460-9568.2008.06560.x. Epub 2008 Dec 11.


A role for brain stress systems in addiction.

Koob GF.

Neuron. 2008 Jul 10;59(1):11-34. doi: 10.1016/j.neuron.2008.06.012. Review.


Activities of mixed NOP and mu-opioid receptor ligands.

Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, Khroyan TV, Husbands SM, Lewis JW, Toll L, Zaveri NT.

Br J Pharmacol. 2008 Feb;153(3):609-19. Epub 2007 Dec 3.


Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward.

Zhao ZQ, Gao YJ, Sun YG, Zhao CS, Gereau RW 4th, Chen ZF.

Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14519-24. Epub 2007 Aug 27.


In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.

Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G.

Peptides. 2007 Jun;28(6):1240-51. Epub 2007 May 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk